[Recommendations for drug therapy in anxiety. Serotoninergic agents to replace benzodiazepines. Drug Administration Office (Sweden) and State Drug Control(Norway)].
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D001569:Benzodiazepines / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D009664:Norway / Q000453:epidemiology; D010698:Phobic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013548:Sweden / Q000453:epidemiology
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D017367:Selective Serotonin Reuptake Inhibitors